Results 111 to 120 of about 615,741 (238)

Processionary Moth Exposure in Europe: Toxic–Irritant and Immunoglobulin E‐Mediated Endotypes, Diagnosis and Management

open access: yesClinical &Experimental Allergy, Volume 56, Issue 9, Page 1017-1030, September 2026.
Most reactions are toxic–irritant, driven by epithelial injury and neuro‐inflammatory activation. IgE‐mediated allergy is less common but may cause immediate systemic reactions. Endotype differentiation guides diagnosis, risk stratification and management.
Prasad Dasari   +9 more
wiley   +1 more source

Diagnosing primary ciliary dyskinesia in Australian adults: 10 years of testing

open access: yesInternal Medicine Journal, Volume 56, Issue 9, Page 1637-1640, September 2026.
Abstract Primary ciliary dyskinesia (PCD) is a rare inherited disorder characterised by impaired ciliary function, leading to chronic upper and lower airway disease from early life. Limited awareness of the condition contributes to delayed diagnosis, with some individuals first diagnosed in adulthood following specialised testing. We describe 91 adults
P. J. Robinson
wiley   +1 more source

Hidden Mould in the Air: A Practical Narrative Mini‐Review of Invasive Mould Infection Prevention for High‐Risk Patients and Clinicians

open access: yesMycoses, Volume 69, Issue 9, September 2026.
ABSTRACT Airborne mould spores, including those of the Aspergillus species, are ubiquitous both indoors and outdoors. While they are generally harmless, inhaled spores can cause severe infections, particularly invasive pulmonary aspergillosis, in patients with impaired immune defences.
Angelika Bauer   +6 more
wiley   +1 more source

Seasonal variation in Allergic Rhinitis/Conjunctivitis/Rhinoconjunctivitis current symptoms

open access: yes, 2015
Seasonal variation in Allergic Rhinitis/Conjunctivitis/Rhinoconjunctivitis current ...
David P. Strachan (110302)   +4 more
core   +1 more source

Allergic rhinitis from the perspective of an allergist

open access: yes, 2019
Allergic rhinitis (AR) is the most common allergic disease. Rational drug therapy should be aimed at nonspecific suppression of the clinical symptoms of AR without taking into account the properties of the allergen.
Olga I. Sidorovich, Liudmila V. Luss
core   +1 more source

Evaluating stapokibart in the treatment of seasonal allergic rhinitis

open access: yesImmunotherapy
Seasonal allergic rhinitis (SAR) is a chronic inflammatory condition primarily mediated by type 2 immune responses, typically triggered by specific pollens. Stapokibart is a humanized monoclonal antibody anti-interleukin-4 receptor α subunit, thereby blocking IL-4 and IL-13 signaling pathways.
Wang, Menglin   +3 more
openaire   +3 more sources

Anti-allergic effect of luteolin in mice with allergic asthma and rhinitis

open access: yes, 2017
Aim of the study : We aimed to evaluate the anti-allergic effect of luteolin treatment in mice with allergic asthma and rhinitis. Material and methods : Thirty-two BALB/c mice (n = 8 for each group) were used.
Jun-Ha Hwang   +5 more
core   +1 more source

Estudo comparativo entre duas técnicas de irrigação nasal no tratamento de pacientes com rinite alérgica. [PDF]

open access: yes, 2006
Trabalho de Conclusão de Curso - Universidade Federal de Santa Catarina. Curso de Medicina.
Duarte, Juliana Antoniolli
core  

GWAS of Second‐Generation Antihistamine Use: Locus Specificity and Highlighted Signalling Pathways

open access: yes
Clinical &Experimental Allergy, EarlyView.
M. Niemi   +15 more
wiley   +1 more source

Psychometric validation of the experience with allergic rhinitis nasal spray questionnaire

open access: yes, 2011
Bruce Crawford1, Richard H Stanford2, Audrey Y Wong3, Anand A Dalal2, Martha S Bayliss11Mapi Values, Boston, MA, USA; 2GlaxoSmithKline, Research Triangle Park, NC, USA; 3BioMedical Insights, San Francisco, CA, USABackground: Patient experience and ...
Wong AY   +4 more
core  

Home - About - Disclaimer - Privacy